BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 33008911)

  • 1. Nanoscale metal-organic frameworks for x-ray activated in situ cancer vaccination.
    Ni K; Lan G; Guo N; Culbert A; Luo T; Wu T; Weichselbaum RR; Lin W
    Sci Adv; 2020 Oct; 6(40):. PubMed ID: 33008911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanoscale Metal-Organic Frameworks for Cancer Immunotherapy.
    Ni K; Luo T; Nash GT; Lin W
    Acc Chem Res; 2020 Sep; 53(9):1739-1748. PubMed ID: 32808760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanomedicines based on nanoscale metal-organic frameworks for cancer immunotherapy.
    Zhong XF; Sun X
    Acta Pharmacol Sin; 2020 Jul; 41(7):928-935. PubMed ID: 32355277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-dose X-ray radiotherapy-radiodynamic therapy via nanoscale metal-organic frameworks enhances checkpoint blockade immunotherapy.
    Lu K; He C; Guo N; Chan C; Ni K; Lan G; Tang H; Pelizzari C; Fu YX; Spiotto MT; Weichselbaum RR; Lin W
    Nat Biomed Eng; 2018 Aug; 2(8):600-610. PubMed ID: 31015630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Nanoscale Metal-Organic Framework to Mediate Photodynamic Therapy and Deliver CpG Oligodeoxynucleotides to Enhance Antigen Presentation and Cancer Immunotherapy.
    Ni K; Luo T; Lan G; Culbert A; Song Y; Wu T; Jiang X; Lin W
    Angew Chem Int Ed Engl; 2020 Jan; 59(3):1108-1112. PubMed ID: 31642163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using PAMPs and DAMPs as adjuvants in cancer vaccines.
    Sun H; Hu W; Yan Y; Zhang Z; Chen Y; Yao X; Teng L; Wang X; Chai D; Zheng J; Wang G
    Hum Vaccin Immunother; 2021 Dec; 17(12):5546-5557. PubMed ID: 34520322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liquid Metal Nanoplatform Based Autologous Cancer Vaccines.
    Wang D; Yu Z; Qi Y; Hu K; Zhou T; Liu J; Rao W
    ACS Nano; 2023 Jul; 17(14):13278-13295. PubMed ID: 37253081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-Z Metal-Organic Frameworks for X-ray Radiation-Based Cancer Theranostics.
    Neufeld MJ; Lutzke A; Pratx G; Sun C
    Chemistry; 2021 Feb; 27(10):3229-3237. PubMed ID: 32902003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A facile approach to preparing personalized cancer vaccines using iron-based metal organic framework.
    Li X; Hattori S; Ebara M; Shirahata N; Hanagata N
    Front Immunol; 2023; 14():1328379. PubMed ID: 38259474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reprogramming of Neutrophils as Non-canonical Antigen Presenting Cells by Radiotherapy-Radiodynamic Therapy to Facilitate Immune-Mediated Tumor Regression.
    Guo N; Ni K; Luo T; Lan G; Arina A; Xu Z; Mao J; Weichselbaum RR; Spiotto M; Lin W
    ACS Nano; 2021 Nov; 15(11):17515-17527. PubMed ID: 34709030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanoscale Metal-Organic Framework Co-delivers TLR-7 Agonists and Anti-CD47 Antibodies to Modulate Macrophages and Orchestrate Cancer Immunotherapy.
    Ni K; Luo T; Culbert A; Kaufmann M; Jiang X; Lin W
    J Am Chem Soc; 2020 Jul; 142(29):12579-12584. PubMed ID: 32658476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenicity-boosted cancer immunotherapy based on nanoscale metal-organic frameworks.
    Li Q; Liu Y; Zhang Y; Jiang W
    J Control Release; 2022 Jul; 347():183-198. PubMed ID: 35526612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Photodynamic Therapy Combined with Antihypoxic Signaling and CpG Adjuvant as an In Situ Tumor Vaccine Based on Metal-Organic Framework Nanoparticles to Boost Cancer Immunotherapy.
    Cai Z; Xin F; Wei Z; Wu M; Lin X; Du X; Chen G; Zhang D; Zhang Z; Liu X; Yao C
    Adv Healthc Mater; 2020 Jan; 9(1):e1900996. PubMed ID: 31746153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanoscale metal-organic frameworks for biomedical imaging and drug delivery.
    Della Rocca J; Liu D; Lin W
    Acc Chem Res; 2011 Oct; 44(10):957-68. PubMed ID: 21648429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Engineered Nanoparticles for Cancer Vaccination and Immunotherapy.
    Aikins ME; Xu C; Moon JJ
    Acc Chem Res; 2020 Oct; 53(10):2094-2105. PubMed ID: 33017150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanoscale Metal-Organic Framework with an X-ray Triggerable Prodrug for Synergistic Radiotherapy and Chemotherapy.
    Xu Z; Zhen W; McCleary C; Luo T; Jiang X; Peng C; Weichselbaum RR; Lin W
    J Am Chem Soc; 2023 Aug; 145(34):18698-18704. PubMed ID: 37581644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanoscale metal-organic frameworks for combined photodynamic & radiation therapy in cancer treatment.
    Liu J; Yang Y; Zhu W; Yi X; Dong Z; Xu X; Chen M; Yang K; Lu G; Jiang L; Liu Z
    Biomaterials; 2016 Aug; 97():1-9. PubMed ID: 27155362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent Progress of Nanoscale Metal-Organic Frameworks in Cancer Theranostics and the Challenges of Their Clinical Application.
    Sun W; Li S; Tang G; Luo Y; Ma S; Sun S; Ren J; Gong Y; Xie C
    Int J Nanomedicine; 2019; 14():10195-10207. PubMed ID: 32099352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chlorin-Based Nanoscale Metal-Organic Framework Systemically Rejects Colorectal Cancers via Synergistic Photodynamic Therapy and Checkpoint Blockade Immunotherapy.
    Lu K; He C; Guo N; Chan C; Ni K; Weichselbaum RR; Lin W
    J Am Chem Soc; 2016 Sep; 138(38):12502-10. PubMed ID: 27575718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engineered exosomes as an in situ DC-primed vaccine to boost antitumor immunity in breast cancer.
    Huang L; Rong Y; Tang X; Yi K; Qi P; Hou J; Liu W; He Y; Gao X; Yuan C; Wang F
    Mol Cancer; 2022 Feb; 21(1):45. PubMed ID: 35148751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.